up, page-16

I think we'll start seeing some regular news flow from here. This new board won't stuff around adding more value to this coy faster than one might expect from the biotech sector.

Their drinking buddy and major s/holder twiggy would also have plenty of spare time to add his own golden touch now that he's stepped away from Fortescue.

I'm not sure BOD's business model was ever based on T/O's although it wouldn't surprise me too much from this point if we start seeing more acquisitions in the future.